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BRIEF DEFINITIVE REPORT
        The typical course of HIV infection for a ma-
jority of untreated individuals is persistent viral 
replication and a gradual loss of CD4  +   T cells. 
One of the consequences of ongoing HIV rep-
lication is increased immune activation, aff  ecting 
all major cell populations of the immune sys-
tem (  1  –  3  ). Within the B cell population, HIV 
infection has been associated with numerous 
perturbations (  4  ), many of which have been at-
tributed to changes in the distribution of B cell 
subpopulations found in the peripheral blood. 
These changes include increased frequencies of 
activated and terminally diff  erentiated B cells 
expressing low levels of CD21 that have been 
associated with ongoing viral replication (  5, 6  ), 
a decreased frequency of memory B cells that 
is not reversed by antiretroviral therapy (  7  ), and 
an increased frequency of immature/transi-
tional B cells that has been associated with CD4  +   
T cell lymphopenia (  8, 9  ). 
  The eff  ects of immune activation in persis-
tent viral infections have recently been shown 
to include virus-specifi  c T cell exhaustion. After 
the original description in chronic lymphocyte 
choriomeningitis virus (LCMV) infection in 
mice (  10  ), observations of virus-specifi  c CD4  +   
and CD8  +   T cell exhaustion have recently been 
extended to HIV-viremic individuals (  11, 12  ). 
Although PD-1 was the fi  rst inhibitory receptor 
associated with virus-specifi  c T cell exhaustion, 
recent fi  ndings suggest that exhaustion may result 
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  Human immunodefi  ciency virus (HIV) disease leads to impaired B cell and antibody re-
sponses through mechanisms that remain poorly defi  ned. A unique memory B cell subpopu-
lation (CD20  hi  /CD27  lo  /CD21  lo  ) in human tonsillar tissues was recently defi  ned by the 
expression of the inhibitory receptor Fc-receptor-like-4 (FCRL4). In this study, we describe 
a similar B cell subpopulation in the blood of HIV-viremic individuals. FCRL4 expression was 
increased on B cells of HIV-viremic compared with HIV-aviremic and HIV-negative individ-
uals. It was enriched on B cells with a tissuelike     memory phenotype (CD20  hi  /CD27       /CD21  lo  ) 
when compared with B cells with a classical memory (CD27  +  ) or naive (CD27       /CD21  hi  ) B 
cell phenotype. Tissuelike memory B cells expressed patterns of homing and inhibitory 
receptors similar to those described for antigen-specifi  c T cell exhaustion. The tissuelike 
memory B cells proliferated poorly in response to B cell stimuli, which is consistent with 
high-level expression of multiple inhibitory receptors. Immunoglobulin diversities and 
replication histories were lower in tissuelike, compared with classical, memory B cells, 
which is consistent with premature exhaustion. Strikingly, HIV-specifi  c responses were 
enriched in these exhausted tissuelike memory B cells, whereas total immunoglobulin and 
infl  uenza-specifi  c responses were enriched in classical memory B cells. These data suggest 
that HIV-associated premature exhaustion of B cells may contribute to poor antibody 
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in the blood of HIV-viremic individuals. Furthermore, we 
fi  nd that HIV-specifi  c B cells are enriched within this B cell 
subpopulation that exhibits many properties associated with 
virus-specifi  c exhaustion. We thus provide evidence for HIV-
associated exhaustion in the B cell compartment that may, in 
part, explain the inadequacy of the anti-HIV antibody response 
in HIV-infected individuals (  16  ). 
    RESULTS AND DISCUSSION   
  Low expression of CD21 on peripheral blood B cells of HIV-
infected individuals identifi  es distinct B cell subpopulations that 
are associated with HIV viremia and lymphopenia (  5, 6, 8, 9  ). 
We previously demonstrated that immature/transitional B 
cells (CD10  +  /CD27       ) account for a fraction of CD21  lo   B 
from the combined eff  ect of increased expression of multiple 
inhibitory receptors (  13, 14  ). 
  The recent characterization of the inhibitory receptor Fc-
receptor-like-4 (FCRL4), expressed on a unique subpopula-
tion of memory B cells in human tonsillar tissues, led to the 
suggestion of an immunoregulatory role for this receptor 
(  15  ). The phenotypic features of these tissue memory B cells 
included increased expression of CD20 and reduced expres-
sion of CD21 and CD27. Given that reduced expression of 
CD21 on peripheral blood B cells is associated with ongoing 
HIV replication (  5, 6  ), we sought to further investigate the 
nature of CD21  lo   B cells in HIV-viremic individuals. We ob-
served that tissuelike CD21  lo   memory B cells expressing high 
levels of FCRL4 and other inhibitory receptors circulate 
    Figure 1.         Phenotypic characterization of tissuelike memory B cells in the peripheral blood of HIV-viremic individuals.   (A) Color-coded gating 
on CD20/CD21-stained B cells of a representative HIV-viremic individual was used to identify CD20  hi /CD21 lo   activated  (CD27 int  ) and tissuelike (CD27      ) 
memory B cells (green); CD20  int /CD21 hi   resting memory (CD27  int  ) and naive (CD27       ) B cells (red); and CD20      /CD27 hi /CD21 lo   plasmablasts (blue). (B) Per-
centage of expression of FCRL4 on peripheral blood B cells of HIV-viremic (  n   = 16), HIV-aviremic (  n   = 12), and HIV-negative individuals (  n   =  12).  Horizontal 
bars indicate medians. (C  –  E) Color-coded gating on CD27/CD21-stained B cells (C and E) of a representative HIV-viremic individual was used to establish 
expression of FCRL4 (C), frequency of FCRL4 on B cell subpopulations of 12 HIV-viremic individuals (D), and other inhibitory/homing receptors and 
adhesion molecules (E) on CD20  hi /CD27     /CD21 lo   tissuelike memory (black), CD27  +   classical memory (blue), and CD20  int /CD27     /CD21 hi   naive (red) B cells. 
MFI, mean fl  uorescence intensity. All stains included CD19, which was used to establish the B cell gate. Immature/transitional B cells were excluded by 
performing stains on CD10-depleted B cells or on PBMCs gated on CD19  + /CD10       cells.   JEM VOL. 205, August 4, 2008  1799
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subpopulations are responsible for the FCRL4 expression 
with  in the CD27  +   B cell compartment (  Fig. 1 C   and not de-
picted). However, for clarity and consistency with the func-
tional data in the following paragraphs, B cells expressing 
CD27 are henceforth collectively referred to as classical memory 
B cells. 
  In addition to FCRL4, tissuelike memory B cells in the 
blood of HIV-viremic individuals expressed relatively high 
levels of other potentially inhibitory receptors (  17, 18  ), in-
cluding CD22, CD85j, CD85k, LAIR-1, and CD72 (  Fig. 1 E   
and   Table I  ). Levels of FCRL4, CD22, and CD85j were 
signifi  cantly higher on tissuelike memory compared with 
classical memory and naive B cells, whereas the expression 
of other inhibitory receptors on tissuelike memory B cells 
was similar or intermediate to that of either naive or classical 
memory B cells (  Table I  ). Furthermore, these tissuelike memory 
B cells in the blood expressed a profi  le of traffi   cking receptors 
similar to that described for tonsillar tissue memory B cells 
(  15  ) (see Ehrhardt et al. [  19  ] on p. 1807 of this issue), namely 
CXCR3  hi  /CD11c  hi  /CCR6  hi  /CCR7  lo  /CXCR5  lo  /CXCR4  lo   
(  Fig. 1 E   and   Table I  ). CXCR3, CD11c, and CCR6 were 
expressed at signifi  cantly higher levels, whereas CCR7, CD62L, 
and CXCR5 were expressed at significantly lower levels 
on tissuelike memory compared with both classical memory 
and naive B cells (  Table I  ). Expression of CXCR4 was 
signifi  cantly lower on both tissuelike and classical memory 
compared with naive B cells (  Table I  ). Collectively, tissuelike 
memory B cells in the blood of HIV-viremic individuals express 
high levels of inhibitory receptors and a profi  le of traffi   ck-
ing receptors that is consistent with migration to chronically 
infl  amed tissues and away from lymphoid tissues that favor 
B  –  T cell interactions (  20  –  23  ). Of note, increased expression 
of multiple inhibitory receptors and alterations in the expression 
cells in CD4  +   T cell  –  lymphopenic individuals (  8, 9  ), whereas 
plasmablasts (CD20       ) account for another fraction of CD21  lo   
B cells in HIV-viremic individuals (  Fig. 1 A  ) (  5, 6  ).   Few of these 
B cells are present in the peripheral blood of HIV-aviremic and 
HIV-negative individuals (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20072683/DC1). However, 
aside from plasmablasts and immature/transitional B cells, we 
observed another population of CD21  lo   B cells in the periph-
eral blood of HIV-viremic individuals; these CD21  lo   B cells 
express high levels of CD20 and low-to-intermediate levels 
of CD27 (  Fig. 1 A  ). Such a profi  le is similar to that of tonsil-
lar tissue memory B cells, defi  ned by the expression of the 
inhibitory receptor FCRL4 (  15  ). 
  To further characterize the peripheral blood-derived 
CD20  hi  /CD27       /CD21  lo   B cells of HIV-viremic individuals, 
which comprise a median of 19% of B cells compared with 
  <  4% in HIV-aviremic and -negative individuals, we measured 
cell surface expression of FCRL4. Peripheral blood mature 
B cells of HIV-viremic individuals expressed signifi  cantly 
higher levels of FCRL4 compared with B cells of HIV-avi-
remic and -negative individuals (  Fig. 1 B  ). The term mature 
B cells, applied here and throughout the manuscript, is used 
to indicate that CD10  +   immature/transitional B cells, which 
do not express FCRL4 (not depicted), were excluded from 
this study. In HIV-viremic individuals, FCRL4 expression 
was increased on tissuelike memory B cells, defi  ned here by 
the expression profi  le CD20  hi  /CD27       /CD21  lo  , compared with 
classical memory (CD27  +  ) and naive (CD20  int  /CD27       /CD21  hi  ) 
B cells (  Fig. 1, C and D,   and   Table I  ).   Of note and illustrated 
in   Fig. 1 A and C  , CD27  +   B cells of HIV-viremic individuals 
are comprised of resting memory (CD20  int  /CD27  int  /CD21  hi  ), 
activated memory B cells (CD20  hi  /CD27  int  /CD21  lo  ), and 
plasmablasts (CD20       /CD27  hi  /CD21  lo  ) (  5, 6  ). The latter two 
    Table I.        Expression of inhibitory and traffi  cking receptors on B cell subpopulations of HIV-viremic individuals 
1 2 3 P values
  Receptor   Classical memory        a       Tissuelike memory   Naive   1 vs. 2   1 vs. 3   2 vs. 3 
Inhibitory
     FCRL4 12 (7.7  –  26)    b   25  (16  –  40) 3.8 (1.5  –  9.7) 0.002 0.0005 0.0005
     CD85j 23 (14  –  40) 49 (24  –  85) 12 (4.4  –  26) 0.002 0.002 0.002
     CD22 197 (81  –  388) 593 (258  –  997) 442 (258  –  655) 0.0005 0.0005 0.028
     CD85k 3.2 (0.8  –  11) 3.4 (0.3  –  12) 1.1 (0.2  –  4.1) 0.25 0.002 0.002
     CD72 20 (7.7  –  29) 62 (20  –  85) 57 (32  –  72) 0.002 0.002 0.270
     LAIR  –  1 23 (12  –  42) 66 (21  –  162) 159 (84  –  250) 0.0005 0.0005 0.002
Traffi  cking
     CXCR3 73 (19  –  153) 222 (55  –  384) 86 (23  –  207) 0.0005 0.136 0.0005
     CD11c 64 (38  –  228) 190 (71  –  365) 38 (8.7  –  185) 0.0005 0.001 0.0005
     CCR6 26 (11  –  49) 54 (24  –  165) 33 (15  –  101) 0.0005 0.003 0.003
     CCR7 9.3 (3.0  –  30) 4.4 (1.4  –  12) 9.8 (2.5  –  30) 0.0005 0.207 0.001
     CD62L 114 (32  –  325) 13 (7.1  –  66) 70 (25  –  370) 0.002 0.176 0.0005
     CXCR5 70 (16  –  147) 40 (8.7  –  126) 177 (96  –  281) 0.021 0.0005 0.002
     CXCR4 8.2 (2.9  –  14) 7.5 (2.9  –  18) 29 (8.7  –  49) 0.478 0.0005 0.002
  a  Refer to   Fig. 1 C   for gating used to identify each subpopulation.
  b  Values are median and range of mean fl  uorescence intensities (  n   = 12) after subtraction of background staining with isotype control.1800 HIV-ASSOCIATED B CELL EXHAUSTION IN HIV INFECTION   | Moir et al. 
ber of cell divisions a B cell has undergone after exiting the 
bone marrow. Initially, we validated the assay on several well-
defi  ned B cell subpopulations that were sorted from the pe-
ripheral blood of HIV-viremic individuals. The number of 
cell divisions was lowest in immature/transitional B cells, fol-
lowed by an increasing number in naive; tissuelike memory; 
resting memory; activated memory; and fi  nally in plasma-
blasts, which underwent the highest number of cell divisions 
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20072683/DC1). The KREC assay was then performed 
on the three B cell subpopulations illustrated in   Fig. 1 C  ; the 
results for one representative individual are depicted in   Fig. 
2 A  .   The number of cell divisions that tissuelike memory 
B cells underwent was signifi  cantly lower than that of classi-
cal memory B cells and signifi  cantly higher than that of naive 
B cells (  Fig. 2 B  ). In addition, we evaluated the degree of 
somatic hypermutation in each fraction using a restriction 
enzyme  –  based hotspot assay that measures Ig VH3 diversity 
(  8, 24, 25  ). Similar to the KREC assay, the Ig VH3 diversity 
assay was performed on the three B cell subpopulations illus-
trated in   Fig. 1 C  , and the results for one representative 
individual are depicted in   Fig. 2 C  . The median Ig VH3 di-
versity index of tissuelike memory B cells was signifi  cantly 
lower and higher compared with that of classical memory and 
naive B cells, respectively (  Fig. 2 D  ). Collectively, these data 
suggest that the tissuelike memory B cells found in the blood 
of HIV-viremic individuals have reached a stage of diff  erenti-
ation and a degree of somatic hypermutation that are inter-
mediate to those of naive and classical memory B cells. 
  Next, we evaluated the proliferative capacities of each 
B cell fraction. Tissuelike memory B cells proliferated signifi  -
cantly less than naive B cells in response to B cell receptor 
(BCR) triggering and CD4  +   T cell help (CD40 ligand; 
CD40L), and/or Toll-like receptor (TLR) 9-triggering with 
type B synthetic CpG oligodeoxynucleotides (CpG-B). Pro-
liferative defi  ciencies in tissuelike memory B cells were not as 
extensive when compared with classical memory B cells, es-
pecially in the presence of all three stimuli (  Fig. 3 A  ), suggest-
ing that inhibitory pressures on tissuelike memory B cells 
may be overridden.   Of note, we have demonstrated that clas-
sical memory B cells of HIV-viremic individuals are them-
selves deficient, especially in response to BCR and CD40 
triggering, when compared with classical memory B cells of 
HIV-aviremic and HIV-negative individuals (  6, 26  ). This de-
fi  ciency in proliferation was explained in part by the presence 
of CD20        plasmablasts among classical memory B cells of 
HIV-viremic individuals (  Fig. 1 C  ). Analysis of CFSE-labeled 
cells indicated that the majority of plasmablasts were short-
lived ex vivo, regardless of culture conditions (not depicted). 
Furthermore, in the presence of B cell stimulatory cytokines 
IL-2 and -10 and CD40L, tissuelike memory and naive B 
cells proliferated at signifi  cantly lower levels compared with 
classical memory B cells, whereas BCR triggering increased 
the proliferation of naive, but not tissuelike, memory B cells 
to levels similar to those observed for classical memory B cells 
(  Fig. 3 B  ). These latter data contrasted with those reported 
of homing receptors CXCR3, CD11c, CCR7, and CD62L 
similar to those described here are signatures of virus-specifi  c 
CD8  +   T cell exhaustion in chronic LCMV infection ( 13  ). Given 
that exhaustion of virus-specifi  c T cells similar to that ob-
served in LCMV has been described in HIV-viremic individuals 
(  11, 12  ), we considered that exhaustion could also be occur-
ring in HIV-specifi  c B cells. 
  To further investigate the hypothesis of B cell exhaustion 
in HIV infection, we fractionated peripheral blood mature 
B cells from HIV-viremic individuals into CD27  +   classical 
memory, CD27       /CD21  lo   tissuelike memory, and CD27       /
CD21  hi   naive B cells. First, we evaluated the in vivo replica-
tion history of each fraction using a recently described PCR-
based assay for measuring     -deletion recombination excision 
circles (KRECs) (  24  ). Given that these circles, which are gen-
erated during the fi  nal stages of Ig gene rearrangements in the 
bone marrow, become diluted by a factor of two each time a 
B cell divides, this approach provides an estimate of the num-
    Figure 2.         Distinct properties of tissuelike memory B cells isolated 
from the peripheral blood of HIV-viremic individuals.  Evaluation  of 
the number of cell divisions undergone in vivo by KREC analysis on ma-
ture (CD10       ) B cells of a representative (A) and a group of HIV-viremic 
individuals (B;   n   = 8) after fractionation into classical memory (CD27  + ), 
tissuelike memory (CD27      /CD21 lo  ), and naive (CD27      /CD21 hi  ) B cells. Eval-
uation of Ig VH3 diversity by restriction enzyme-based hotspot analysis 
on mature B cells of a representative (C) and a group of HIV-viremic indi-
viduals (D;   n   = 8) after fractionation into classical memory, tissuelike 
memory, and naive B cells. Each individual is identifi  ed by a different color 
in B and D.     JEM VOL. 205, August 4, 2008  1801
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each fraction after polyclonal stimulation ex vivo. Of note, 
these culture conditions, whereas unfavorable to the short-
lived plasmablasts that are responsible for the spontaneous se-
cretion of Igs in HIV disease (not depicted) (for review see 
[  4  ]), are required for the induction of ASCs from all other 
B cell subpopulations. Total Ig ASC frequencies were signifi  -
cantly higher in classical memory compared with tissuelike 
memory and naive B cells (  Fig. 4 A  ).   There was no diff  erence 
in total Ig ASC frequencies between tissuelike memory and 
naive B cells (  Fig. 4 A  ). However, as one would predict, fre-
quencies of IgM ASCs were signifi  cantly higher than IgG/A 
ASCs in the naive B cell fraction (  Fig. 4 B  ; P = 0.002), 
whereas there was no diff  erence between isotypes in the tis-
suelike memory B cell fraction (  Fig. 4 B  ). Also as expected, 
frequencies of IgG/A ASCs were signifi  cantly higher than 
IgM ASCs in the classical memory B cell fraction (  Fig. 4 B  ; 
for tonsil-derived FCRL4  +   B cells, which responded robustly 
to IL-2 and -10 (  15  ). This diff  erence may be explained by the 
presence of IL-2/-10  –  responsive CD27  +   B cells among the 
tonsil-derived FCRL4  +  , but not among our blood-derived 
tissuelike memory B cells (  Fig. 3 B  ) (  15  ). Nonetheless, these 
data indicate that tissuelike memory B cells found in the 
blood of HIV-viremic individuals exhibit proliferative defi  -
ciencies when compared with naive and classical memory B 
cells. The low proliferative capacity of these B cells may be 
caused by the overexpression of inhibitory receptors, which 
is consistent with their reduced replication history in vivo 
(  Fig. 2, A and B  ). These data are also consistent with the low 
proliferative capacity that has been shown for exhausted HIV-
specifi  c T cells in HIV-viremic individuals (  11, 12  ). 
  Next, we measured frequencies of antibody-secreting B 
cells (ASCs), including total Ig and antigen-specifi  c ASCs, in 
    Figure 3.         Low proliferative capacity of tissuelike memory B cells isolated from the peripheral blood of HIV-viremic individuals. 
  (A and B) Proliferation was measured in response to various B cell stimuli in the absence (A) or presence (B) of cytokines on mature B cells that had 
been fractionated into classical memory, tissuelike memory, and naive B cells (  n   = 8). Anti-Ig refers to goat anti  –  human IgG/A/M antibodies, and CpG 
refers to CpG type B, which is described in the Materials and methods. Horizontal bars indicate medians, and tissue memory in the graphs refers to 
tissuelike memory.     1802 HIV-ASSOCIATED B CELL EXHAUSTION IN HIV INFECTION   | Moir et al. 
There were no differences between IgG/A and IgM ASC 
frequencies against HIV within fractions (  Fig. 4 F  ), except for 
naive B cells (IgG/A   >   IgM; P = 0.004). The reason for this 
diff  erence is unclear, but may be explained by the presence of 
recently described IgG  +  /CD21  +  /CD27        memory B cells in 
this fraction (  27  ), or by HIV-induced in vivo priming of 
CD21  +   B cells (  28, 29  ), leading to preferential expansion and 
class switching ex vivo. Nonetheless, these data clearly indi-
cate that although total Ig and recall antigen ASCs were most 
prominent in classical memory B cells, HIV-specifi  c ASCs 
were enriched in tissuelike memory B cells. 
  We previously demonstrated that CD21  lo   B cells of HIV-
viremic individuals expressed increased levels of markers of 
activation, turnover, and differentiation, including CD80, 
CD86, CD95, Ki-67, and CD38 (  6  ). Phenotypic analyses of 
the three subpopulations investigated in the current study 
demonstrated that the CD21  lo   B cells within the classical, 
P = 0.02). Collectively, these data indicate that tissuelike mem-
ory B cells fall between naive and classical memory B cells 
with regard to the extent of class switching. These data are 
consistent with the levels of somatic hypermutation shown in 
  Fig. 2 (C and D)  . 
  Finally, we measured ASC frequencies against the HIV 
envelope gp120 and infl  uenza hemagglutinin, a recall anti-
gen chosen for its widespread representation in our HIV-in-
fected cohort as a result of annual vaccination campaigns. 
As expected, the frequency of infl  uenza-specifi  c ASCs was 
signifi  cantly higher in classical memory B cells compared 
with tissuelike memory and naive B cells (  Fig. 4 C  ). There 
were no diff  erences between IgG/A and IgM ASC frequencies 
against infl  uenza within fractions (  Fig. 4 D  ). When the HIV 
response was evaluated, a signifi  cantly higher frequency of 
HIV-specifi  c ASCs was observed in tissuelike memory B cells 
compared with classical memory and naive B cells (  Fig. 4 E  ). 
    Figure 4.         Enrichment of HIV-specifi  c ASCs in tissuelike memory B cells contrasted by enrichment of total and infl  uenza-specifi  c ASCs in 
classical memory B cells.   Total Ig ASCs     (A) and Ig isotypes of total ASCs (B) in classical memory, tissuelike memory, and naive B cells after in vitro 
polyclonal stimulation (  n   = 13). Total infl  uenza-specifi  c ASCs (C) and Ig isotypes of infl  uenza-specifi  c ASCs (D) in classical memory, tissuelike memory, 
and naive B cells after in vitro polyclonal stimulation (  n   = 12). Total HIV-specifi  c ASCs (E) and Ig isotypes of HIV-specifi  c ASCs (F) in classical memory, 
tissuelike memory, and naive B cells after in vitro polyclonal stimulation (  n   = 13). V01-V15 along the x axis of B, D, and F identifi  es each individual tested, 
and the asterisk indicates that only IgG was tested on this individual. Horizontal bars indicate medians, and tissue memory in the graphs refers to tissue-
like memory.     JEM VOL. 205, August 4, 2008  1803
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isolated from PBMCs by negative magnetic bead  –  based selection using a B 
cell enrichment cocktail that was supplemented with tetrameric anti-CD10 
mAb (StemCell Technologies). This approach excluded immature/transi-
tional B cells, which are overrepresented in HIV-infected individuals with 
active disease (  8  ), and would have confounded the results in the current 
study. Phenotypic analyses were performed with anti  –  human mAbs mostly 
obtained from BD Biosciences, with the following exceptions: anti  –  human 
CD21 was obtained from Beckman Coulter; anti  –  human CD85j, CD85k, 
CXCR3, CCR6, CCR7, CXCR4, and CXCR5 were obtained from R  &  D 
Systems; anti  –  human CD11c was obtained from Invitrogen; and anti  –  hu-
man FCRL4 was obtained from M.D. Cooper (Emory Univeristy School of 
Medicine. Atlanta, GA) (  15  ), and its secondary was anti  –  mouse IgG2a (Invi-
trogen). FACS analyses were performed on a FACSCalibur fl  ow cytometer 
(BD Biosciences) using FlowJo software (Tree Star, Inc.). 
  B cell fractionation.     Mature B cells were separated into CD27  +  , CD27       /
CD21  hi  , and CD27       /CD21  lo   fractions using a two-step magnetic bead-
based selection process. Cells were fi  rst fractionated by CD27 with biotinyl-
ated anti-CD27 (BioLegend), followed by anti-biotin Microbeads (Miltenyi 
Biotech), and recovery of fractions according to manufacturer specifi  cations. 
Purities of CD27  +   and CD27        fractions were typically   >  85% and   >  95%, re-
spectively. The CD27        fraction was further fractionated with anti  –  CD21-
FITC, followed by anti-FITC Microbeads (Miltenyi Biotech), and recovered 
according to manufacturer specifi  cations. Purities after CD21 fractionation 
were typically   >  85%. Alternatively, in some individuals where fractions 
were only to be used for molecular analyses, fractionation was done by cell 
sorting on a FACSAria instrument (BD Biosciences). Mature B cells were 
fractionated with anti  –  CD20-FITC (BD Biosciences) for plasmablast ana-
lyses and with anti  –  CD21-biotin (Ancell) for CFSE-based analyses, each fol-
lowed by appropriate Microbead-based selection. 
  KREC assay.     The ratio of KREC joints (signal joint) to the J    -C     recom-
bination genomic joints (coding joint) was determined as previously de-
scribed (  24  ). In brief, genomic DNA was isolated from each B cell fraction 
by lysing cell pellets in 10 mM Tris-HCl, pH 8.0, containing 100   μ  g/ml 
proteinase K (Roche), incubating for 1 h at 56  °  C, and heat inactivating the 
enzyme at 95  °  C for 10 min. Two separate PCR reactions were performed 
on     50 ng DNA each (based on the approximation of 6 pg DNA per cell), 
one reaction to amplify the signal joint and the other to amplify the coding 
joint, as previously detailed (  24  ). The number of cell divisions was calculated 
by subtracting the cycle threshold of the PCR detecting the coding joint 
from that of the PCR detecting the signal joint. 
  Somatic hypermutation analysis.     A restriction enzyme-based hotspot 
assay was used to evaluate Ig VH3 diversifi  cation as previously described 
(  25  ), with recently described modifi  cations (  8  ). In brief, cell pellets from B 
cell fractions were lysed in RNA buff  er (RNeasy; QIAGEN) and the RNA 
was reverse transcribed with a JH consensus reverse primer. The cDNA was 
amplifi  ed with a Cy5-labeled VH3 consensus forward primer and the JH 
consensus reverse primer. The PCR products were digested with Alu I and 
separated on a polyacrylamide gel, and band intensities were measured using 
a PhosphorImager (Molecular Dynamics). The Ig VH3 diversity index was 
defi  ned as the ratio of uncut PCR product in the presence of Alu I to uncut 
PCR product in the absence of Alu I. 
  Proliferation assay.     This assay was performed as previously described (  5  ). 
In brief, cells were plated at 1   ×   10  5   cells per well of a 96-well fl  at-bottom 
plate with various combinations of the following reagents: 20 U/ml IL-2 
(Roche); 100 ng/ml IL-10 (R  &  D Systems); 10   μ  g/ml goat anti  –  human 
IgG/A/M (Jackson ImmunoResearch Laboratories); 500 ng/ml CD40 li-
gand (  5  ); and phosphorothiolated CpG oligodeoxynucleotide type B (CpG-
B; 2.5   μ  g/ml; Operon). Cells were incubated for 72 h and pulsed for 16 h 
with tritiated thymidine. Proliferation was also assessed by FACS analysis of 
cells labeled with CFSE (Invitrogen). 
but not tissuelike, memory B cells were largely responsible for 
these increases (Table SI and SII, available at http://www
.jem.org/cgi/content/full/jem.20072683/DC1). Of note, 
plasmablasts, which represent a median of 5.5% of B cells 
in the peripheral blood of HIV-viremic individuals, expressed 
the highest levels of CD86, Ki-67, and CD38 (Table SII). 
Collectively, our current and previous fi  ndings demonstrate 
heterogeneous eff  ects of HIV disease on B cells. These include 
lymphopenia associated with the appearance in blood of 
immature/transitional B cells (  8, 9  ), and increased cell turnover/
activation/diff  erentiation (CD27  +  /CD21  lo   B cells) and exhaus-
tion (CD27       /CD21  lo   B cells) associated with viremia. 
  In summary, we provide evidence for HIV-associated B cell 
exhaustion during HIV viremia. We have identifi  ed a unique 
population of tissuelike memory B cells in the blood of HIV-
viremic individuals that are enriched with HIV-specifi  c B cells 
and bear several of the same features that have been associated 
with virus-induced exhaustion of T cells (  10  –  14  ). Evidence of 
exhaustion include increased expression of multiple inhibitory 
receptors; altered expression of homing receptors; reduced 
proliferative potential; and stunted replication history and 
Ig diversity. Alternatively, these stunted features may refl  ect 
reduced CD4  +   T cell help and other factors required for pro-
ductive B cell responses, and/or overriding eff  ects of increased 
inhibitory receptor expression. Given that overexpression of 
FCRL4 on tissuelike and, to a lesser extent, classical memory 
B cells in the blood is a feature unique to HIV infection, 
it is tempting to speculate that FCRL4 is key to the inhibi-
tory properties suggested by our fi  ndings. However, FCRL4 
remains a putative inhibitory receptor with no known ligand. 
Furthermore, it is conceivable that it is the overall increase 
in multiple inhibitory receptors on tissuelike memory B cells 
that may contribute to their premature exhaustion, as has 
been discussed for exhausted LCMV-specifi  c CD8  +   T cells 
(  13  ). Without better tools to analyze virus-specifi  c B cells at 
the single-cell level, many of these concepts regarding dys-
function of B cells by exhaustion will remain somewhat spec-
ulative. Nonetheless, our fi  ndings suggest that HIV-specifi  c 
responses are enriched in a compartment of tissuelike memory 
B cells in HIV-viremic individuals that exhibit many features 
of premature exhaustion. These fi  ndings may help explain in 
part the relatively ineff  ective HIV-specifi  c antibody response 
in viremic, infected individuals. 
    MATERIALS AND METHODS   
  Study subjects.     Leukapheresis and blood draw products were obtained from 
study subjects. We recruited 40 untreated HIV-viremic individuals (median 
plasma viremia: 18,606 [range 106  –  264,747] copies HIV RNA/ml), 12 anti-
retroviral-treated HIV-aviremic individuals (plasma viremia   <  50 copies HIV 
RNA per ml), and 12 HIV-negative individuals. HIV plasma viremia was 
measured by branched DNA assay (Bayer Diagnostics), with a lower limit of 
detection of 50 copies per ml. All study subjects provided informed consent, 
in accordance with the Institutional Review Board of the National Institute 
of Allergy and Infectious Diseases, National Institutes of Health. 
  Phenotypic analysis.     Peripheral blood mononuclear cells (PBMCs) were 
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  ELISpot assay.     HIV-viremic individuals who were likely to have a B cell 
response to the infl  uenza vaccine formulation of 2006  –  2007, either from 
vaccination or natural infl  uenza infection, were selected for this assay. The 
ELISPOT assays were performed as previously described (  30  ), with the fol-
lowing modifi  cations. Each B cell fraction was plated at 1  –  2   ×   10  6   cells/well 
in 24-well plates and incubated in the presence of 1/10,000   Staphylococcus 
aureus   Cowan (EMD Biosciences) and 2.5   μ  g/ml CpG-B. 96-well nitrocel-
lulose fi  ltration plates (MAHAS45; Millipore) were coated overnight at 4  °  C 
with the following: 5   μ  g/ml each anti  –  human      and anti  –  human      (Rock-
land); 5   μ  g/ml ancestral HIV gp120 (  31  ); 5   μ  g/ml infl  uenza vaccine formu-
lation for 2006  –  2007 (Sanofi-Pasteur); and 5   μ  g/ml keyhole limpet 
hemocyanin control antigen (EMD Calbiochem). The HIV gp120 protein 
was produced and purifi  ed as previously described (  32  ). Wells were blocked 
with RPMI containing 5% FCS for 2 h at room temperature before use. At 
day 4, cells were collected, counted, and transferred to coated plates at two 
diff  erent dilutions, ranging from 3,000  –  300,000 cells/well depending on the 
coating antigen or antibody. Cells were incubated at 37  °  C for 5 h, after 
which plates were washed and incubated overnight at 4  °  C with biotinylated 
anti  –  human IgG (1:20,000; Jackson), IgA (1:5,000; BD Biosciences), or IgM 
(1:5,000; BD Biosciences). Plates were washed, incubated with substrate 
(ELISpot Blue; R  &  D Systems), dried, and spots were enumerated with an 
automated Immunospot Series 3A analyzer and software (Cellular Technol-
ogy). The number of antigen-specifi  c spots was adjusted for background by 
subtracting spots in the keyhole limpet hemocyanin wells from those in the 
test wells and adjusting for the number of input cells. All washes were per-
formed with PBS containing 0.25% Tween-20 (PBS-T) and anti  –  human Igs 
were diluted in PBS-T containing 1% FCS. For analyses of spontaneous 
antibody secretion, freshly isolated cells were plated directly onto antigen-
coated plates, as previously described (  30  ). 
  Statistical analyses.     The three groups of individuals (  Fig. 1 B  ) were 
compared simultaneously using the Kruskall-Wallis test, which, if signifi  -
cant at level 0.05, prompted pairwise comparisons by Wilcoxon rank sum 
tests. This approach of predicating pairwise comparisons on a signifi  cant 
result for the simultaneous test provides strong control of the family-wise 
error rate when there are three comparisons. B cell subpopulations (  Table I  ; 
Table S1; and Table S2;   Fig. 1 D  ;   Fig. 2, B and D  ;   Fig. 3  ; and   Fig. 4, 
A, C, and E  ) were compared simultaneously by the Friedman test which, 
if signifi  cant, prompted pairwise comparisons by Wilcoxon signed rank 
tests. Comparisons between switched and unswitched immunoglobulin 
isotypes (  Fig. 4, B, D, and F  ) were made by Wilcoxon signed rank tests. 
  Online supplemental material.     Fig. S1 shows the B cell subpopulations that 
are present in the peripheral blood of HIV-aviremic and -negative individuals. 
Fig. S2 shows the replicative histories of various B cell sub  populations 
isolated from the peripheral blood of two HIV-viremic individuals. Tables S1 
and S2 depict diff  erences in the expression of activation markers and Ki-67 
on and in the various B cell subpopulations, with Table S1 comparing ex-
pression between classical memory, tissuelike memory, and naive B cells 
and Table S2 comparing expression within subpopu  lations of the classical 
memory B cell compartment. The online version of this article is available at 
http://www.jem.org/cgi/content/full/jem.20072683/DC1. 
  We thank M.D. Cooper and G. Ehrhardt (Emory University School of Medicine) for helpful 
discussions. We are grateful to the patients for their willingness to participate in our study. 
  This work was supported by the Intramural Research Program of National 
Institute of Allergy and Infectious Diseases, National Institutes of Health. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   19 December 2007 
Accepted:   10 June 2008 
  REFERENCES 
       1  .   Giri  ,   M.S.  ,   M.     Nebozhyn  ,   L.     Showe  , and   L.J.     Montaner  .   2006  . 
  Microarray data on gene modulation by HIV-1 in immune cells: 2000-
2006.       J. Leukoc. Biol.       80  :  1031    –    1043  .    JEM VOL. 205, August 4, 2008  1805
BRIEF DEFINITIVE REPORT
        22  .   Miyasaka  ,   M.  , and   T.     Tanaka  .   2004  .   Lymphocyte traffi   cking  across 
high endothelial venules: dogmas and enigmas.       Nat. Rev. Immunol.     
  4  :  360    –    370  .    
        23  .   Allen  ,   C.D.  ,   T.     Okada  , and   J.G.     Cyster  .   2007  .   Germinal-center organi-
zation and cellular dynamics.       Immunity      .     27  :  190    –    202  .    
        24  .   van Zelm  ,   M.C.  ,   T.     Szczepanski  ,   M.     van der Burg  , and   J.J.     van Dongen  . 
  2007  .   Replication history of B lymphocytes reveals homeostatic prolif-
eration and extensive antigen-induced B cell expansion.       J. Exp. Med.     
  204  :  645    –    655  .    
        25  .   Bonhomme  ,  D.  ,  L.    Hammarstrom  ,  D.    Webster  ,  H.    Chapel  ,  O.    Hermine  , 
  F.     Le Deist  ,   E.     Lepage  ,   P.H.     Romeo  , and   Y.     Levy  .   2000  .   Impaired an-
tibody affi   nity maturation process characterizes a subset of patients with 
common variable immunodefi  ciency.       J. Immunol.       165  :  4725    –    4730  .   
        26  .   Malaspina  ,   A.  ,   S.     Moir  ,   A.C.     DiPoto  ,   J.     Ho  ,   W.     Wang  ,   G.     Roby  ,   M.A.   
  O’Shea  , and   A.S.     Fauci  .   2008  .   CpG oligonucleotides enhance prolif-
erative and eff  ector responses of B cells in HIV-infected individuals.   
    J. Immunol.       181  :  1199    –    1206  .   
        27  .   Fecteau  ,   J.F.  ,   G.     Cote  , and   S.     Neron  .   2006  .   A new memory CD27-
IgG+ B cell population in peripheral blood expressing VH genes with 
low frequency of somatic mutation.       J. Immunol.       177  :  3728    –    3736  .   
      28  .   Kacani  ,   L.  ,   W.M.     Prodinger  ,   G.M.     Sprinzl  ,   M.G.     Schwendinger  ,   M.   
  Spruth  ,   H.     Stoiber  ,   S.     Dopper  ,   S.     Steinhuber  ,   F.     Steindl  , and   M.P.     Dierich  . 
  2000  .   Detachment of human immunodefi  ciency virus type 1 from germinal 
centers by blocking complement receptor type 2.       J. Virol.       74  :  7997    –    8002  .    
        29  .   Moir  ,   S.  ,   A.     Malaspina  ,   Y.     Li  ,   T.W.     Chun  ,   T.     Lowe  ,   J.     Adelsberger  , 
  M.     Baseler  ,   L.A.     Ehler  ,   S.     Liu  ,   R.T.     Davey     Jr  .,   et al  .   2000  .   B cells 
of HIV-1  –  infected patients bind virions through CD21  –  complement 
interactions and transmit infectious virus to activated T cells.       J. Exp. 
Med.       192  :  637    –    646  .    
        30  .   Malaspina  ,   A.  ,   S.     Moir  ,   S.M.     Orsega  ,   J.     Vasquez  ,   N.J.     Miller  ,   E.T.   
  Donoghue  ,   S.     Kottilil  ,   M.     Gezmu  ,   D.     Follmann  ,   G.M.     Vodeiko  ,   et al  . 
  2005  .   Compromised B cell responses to infl  uenza vaccination in HIV-
infected individuals.       J. Infect. Dis.       191  :  1442    –    1450  .    
        31  .   Doria-Rose  ,   N.A.  ,   G.H.     Learn  ,   A.G.     Rodrigo  ,   D.C.     Nickle  ,   F.     Li  , 
  M.     Mahalanabis  ,   M.T.     Hensel  ,   S.     McLaughlin  ,   P.F.     Edmonson  ,   D.   
  Montefi  ori  ,   et al  .   2005  .   Human immunodefi  ciency virus type 1 sub-
type B ancestral envelope protein is functional and elicits neutralizing 
antibodies in rabbits similar to those elicited by a circulating subtype 
B envelope.       J. Virol.       79  :  11214    –    11224  .    
        32  .   Mossman  ,   S.P.  ,   F.     Bex  ,   P.     Berglund  ,   J.     Arthos  ,   S.P.     O  ’  Neil  ,   D.     Riley  , 
  D.H.     Maul  ,   C.     Bruck  ,   P.     Momin  ,   A.     Burny  ,   et al  .   1996  .   Protection 
against lethal simian immunodefi  ciency virus SIVsmmPBj14 disease by a 
recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit 
vaccine.       J. Virol.       70  :  1953    –    1960  .                 